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Expression of differentiation markers in EBs
Marker	 WT,	n	=	3	 Gsk3a–/–,	n	=	3	 Gsk3b–/–,	n	=	3
Nanog 2.19 ± 0.16 1.82 ± 0.19 1.57 ± 0.11
Brachyury 2.53 ± 0.28 3.26 ± 0.66 0.82 ± 0.18A
GATA4 0.88 ± 0.27 0.89 ± 0.13 0.89 ± 0.03
Nkx2.5 2.13 ± 0.74 3.13 ± 0.46 1.08 ± 0.20
β-MHC 4.69 ± 0.46 2.39 ± 0.56B 0.93 ± 0.07A,B
α-MHC 5.69 ± 0.95 3.42 ± 0.45B 0.87 ± 0.17A,B
SERCA2 2.43 ± 0.15 1.96 ± 0.24 1.03 ± 0.05A,B
BNP 6.18 ± 0.87 4.25 ± 0.23 1.18 ± 0.12A,B
Values are arbitrary units (mean ± SEM). AP < 0.05 versus Gsk3a–/–;  
BP < 0.05 versus WT. BNP, B-type natriuretic peptide; β-MHC, β–myo-
sin heavy chain; SERCA2, sarcoplasmic reticulum Ca2+-ATPase.
Table 2
Survival of mutant embryos
Time	point	 	 Gsk3b+/+	 Gsk3b+/–	 Gsk3b–/–	 c2	P	value
E12.5–E15.5 51 99 40 NS
E16.5–E19.5 23 55 19 NS
Values indicate total number of embryos genotyped at each gesta-
tional age.
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Histological analysis of heart development in GSK-3β–deficient mice. Sequential rostral-to-caudal sections from an E15.5 Gsk3b–/– embryo 
from the pulmonary valve (top left) to the ventricles (bottom right) (original magnification, ×2.0; scale bar: 0.5 cm). The pulmonary valve and the 
pulmonary artery (P) are positioned over the RV (A–C). Below the pulmonary valve, the aorta (A) descends toward the aortic valve (D–F); the 
aortic valve is positioned over the RV (G). Caudal to the semilunar valves, the RV and the LV are connected by a VSD (H–K). The location of 
the VSD is in the membranous portion of the interventricular septum.
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GSK-3β deficiency alters expression and/or nuclear partitioning of car-




Analysis of ventricular development. H&E-stained sections of Gsk3b+/+ (left) and Gsk3b–/– (right) hearts (original magnification, ×2.5; scale bars: 
0.1 mm) including the mitral valve leaflet (A) and the tricuspid valve leaflet (B) (original magnification, ×2.5; scale bars: 0.5 mm). The atrio-
ventricular valve leaflets of Gsk3b–/– embryos showed cellularity, chordal attachment, and dimension comparable to those of control embryos. 
By comparison, the LV wall thickness was greatly increased in the Gsk3b–/– embryo hearts. (C) Quantification of thickness of the LV free wall, 
interventricular septum, and RV free wall in Gsk3b+/+ (n = 4) and Gsk3b–/– (n = 6) hearts. Error bars indicate mean ± SEM. *P < 0.05 versus WT. 
(D) The pulmonary vasculature and parenchyma showed congestion of blood in Gsk3b–/– (right) compared with Gsk3b+/+ (left) embryos (original 
magnification, ×1.6; scale bars: 0.5 mm). (E) TNFR1 deficiency does not rescue the cardiac phenotype of Gsk3b–/– embryo hearts. Sections of 
Tnfr1–/– (left) and Gsk3b–/–Tnfr1–/– (right) embryos, including the tricuspid valve leaflet (original magnification, ×1.6; scale bars: 0.5 mm).
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tion in GSK-3β–deficient hearts. 
(A) Immunofluorescence staining 
for nuclear phospho–histone H3 
(Ser10) (left panels) in GSK-3β– 
deficient (bottom) compared with 
WT (top) animals. Merging of the 
histone and the DAPI (middle) 
stains confirmed nuclear localiza-
tion of the phospho–histone H3 
(Ser10) staining (right panels). 
Original magnification, ×40. (B) 
Composite mean ± SEM per-
centage of phospho–histone H3 
(Ser10)–staining cells at E13.5 and 
E15.5 in the myocardium of WT 
(white bars) and GSK-3β–deficient 
(back bars) animals.*P < 0.05, 
**P < 0.001 versus WT. (C) Coim-
munostaining of heart sections with 
phospho–histone H3 and GATA4, 
a cardiomyocyte marker, demon-
strating colocalization in the over-
lay. Thus, the phospho–histone 
H3 (Ser10)–positive cells in the 
myocardium are overwhelmingly 
GATA4 positive, consistent with 
cardiomyocytes. Also shown is 
nuclear staining with DAPI. Original 
magnification, ×40.
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Altered transcription factor and cell cycle regulator expression and local-
ization in GSK-3β–deficient hearts. (A) Increased nuclear cyclin D1 in 
hearts of E15.5 GSK-3β–deficient embryos. Sections were stained with 
anti–cyclin D1 antibody (brown) and then counterstained with hema-
toxylin to identify nuclei (blue). Note the multiple dark brown nuclei 
(arrowheads) and the overall increase in cyclin D1 stain and corre-
sponding decrease in intensity of the hematoxylin stain in the GSK-3β– 
deficient hearts. Original magnification, ×40. (B) c-Myc expression is 
increased in GSK-3β–deficient hearts. Sections from E15.5 embryos 
were stained with anti–c-Myc antibody (brown) and then counterstained 
with hematoxylin as described above. Note the enhanced brown stain-
ing of the nuclei (arrowheads) and the reduction in intensity of the 
hematoxylin stain, consistent with increases in nuclear c-Myc expres-
sion in the GSK-3β–deficient heart. Original magnification, ×40.
Figure 5
Increased nuclear GATA4 expression in GSK-3β–deficient hearts. GATA4 staining (left) 
was located over nuclei in the hearts of E13.5 embryos stained by DAPI (center) in 
merged images (right). Original magnification, ×40.
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GATA4 overexpression drives cardiomyocyte proliferation. (A) GSK-3 
inhibition increases neonatal rat ventricular myocyte (NRVM) prolifera-
tion. Shown is the mean ± SEM percentage of phospho–histone H3 
(Ser10)–staining cells 20 hours following LiCl and 6-bromoindirubin-
3ʹ-oxime (BIO) treatment at the indicated concentrations. (B) GATA4 
overexpression induces NRVM proliferation. Immunoblot of lysates 
from NRVMs infected with adenovirus encoding LacZ (left 2 lanes) or 
GATA4 (right 2 lanes). NRVMs were treated with 100 viral particles per 
cell (first and third lanes) or 200 particles per cell (second and fourth 
lanes). NRVMs plated onto glass coverslips were stained for phospho–
histone H3 (Ser10) 48 hours after infection of cells with adenoviruses 
(200 viral particles per cell) encoding GATA4 (Ad-GATA4) or LacZ 
(Ad-LacZ). Shown is the mean ± SEM percentage of phospho–histone 
H3 (Ser10)–staining cells following Ad-LacZ or Ad-GATA4 infec-
tion. *P < 0.05, **P < 0.01, ***P < 0.001 versus vehicle control (Ctrl); 
†P < 0.001 versus Ad-LacZ.
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phosphatidylinositol  3-kinase  pathway  and 
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GATA6  expression  is  required  for  cardiovas-
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